Table: Immuno Biological Lab -2022/23 group forecast
Apr 27 (Reuters) -
Immuno Biological Laboratories Co Ltd
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Mar 31, 2023 Mar 31, 2023
LATEST PREVIOUS
FORECAST FORECAST
Sales 794 mln 775 mln
Operating 58 mln 3 mln
Recurring loss 127 mln loss 95 mln
Net loss 289 mln loss 120 mln
EPS loss 31.10 yen loss 12.88 yen
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T